The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.
Oxford Nanopore, a UK-based genetic sequencing technology spinout of University of Oxford, attracted £29.3m ($38.5m) of funding on Thursday from undisclosed new and existing investors in the US, Europe and Asia-Pacific.
Existing investors additionally sold $106m in a secondary transaction, including $28.9m in shares sold by commercialisation firm IP Group, which now owns 16.4% interest at a valuation of around $347m.
According to the Telegraph, the secondary element included 12% disposed by defunct investment firm Woodford Investment Management…
